Exhibit 99.1

FOR IMMEDIATE RELEASE		4714 Gettysburg Road
		Mechanicsburg, PA 17055
		NYSE Symbol: SEM

Select Medical Holdings Corporation Announces Results for
Fourth Quarter and Year Ended December 31, 2009

MECHANICSBURG, PENNSYLVANIA — February 18, 2010 — Select Medical Holdings Corporation (“Select”) (NYSE: SEM), today announced results for its fourth quarter and year ended December 31, 2009.

For the fourth quarter ended December 31, 2009, net operating revenues increased 4.8% to $573.5 million compared to $547.1 million for the same quarter, prior year. Income from operations increased 21.6% to $69.9 million compared to $57.5 million for the same quarter, prior year. Net income attributable to Select increased to $29.9 million compared to $8.8 million for the same quarter, prior year. Additionally, net income before interest, income taxes, depreciation and amortization, gain (loss) on early retirement of debt, stock compensation expense, other expense, long-term incentive compensation and non-controlling interest (“Adjusted EBITDA”) for the fourth quarter increased 14.9% to $87.9 million compared to $76.5 million for the same quarter, prior year. A reconciliation of net income to Adjusted EBITDA is attached to this release. Income per common share was $0.19 on a fully diluted basis compared to $0.04 for the same quarter prior year.

For the year ended December 31, 2009, net operating revenues increased 4.0% to $2,239.9 million compared to $2,153.4 million for the prior year. Income from operations increased 20.1% to $235.8 million compared to $196.4 million for the prior year. Income from operations for the year ended December 31, 2009 includes compensation costs of $22.0 million Select incurred associated with its initial public offering of common stock. Net income attributable to Select increased to $75.3 million compared to $22.4 million for the prior year. Additionally, Adjusted EBITDA for the year ended December 31, 2009 increased 22.2% to $330.2 million compared to $270.3 million for the prior year. Earnings per share were $0.61 on a fully diluted basis compared to a loss of $0.04 per common share for the prior year.

Select’s income per common share for the quarter and year ended December 31, 2009 includes certain non-recurring items, such as long-term incentive compensation, stock expense related to the grant of restricted stock upon Select’s initial public offering and gains and losses related to the early retirement of debt. Other than the gains on early retirement of debt, the non-recurring items relate to Select’s initial public offering of common stock. Excluding these items, on an adjusted basis income available to common stockholders was $0.20 per diluted share for the fourth quarter ended December 31, 2009 compared to $0.03 for the same quarter prior year and $0.67 per diluted share for the year ended December 31, 2009 compared to a loss per common share of $0.04 for the prior year. A reconciliation of net income per share to adjusted net income per share is attached to this release.

Specialty Hospitals

At December 31, 2009, Select operated 89 long term acute care hospitals and six acute medical rehabilitation hospitals. This compares to 88 long term acute care hospitals and five acute medical rehabilitation hospitals operated at December 31, 2008. For the fourth quarter of 2009, net operating revenues for all of Select’s hospitals increased 4.6% to $401.4 million compared to $383.7 million for the same quarter, prior year. Total patient days for the fourth quarter of 2009 were 258,013, admissions were 10,899 and net revenue per patient day was $1,528. This compares to 249,626 days, 10,286 admissions and net revenue per patient day of $1,509 for the same quarter, prior year. For the hospitals opened or acquired as of January 1, 2008 and operated by Select throughout both periods, patient days in the fourth quarter of 2009 were 238,583 and admissions were 10,096, compared to 235,381 days and 9,720 admissions in the same quarter, prior year. Adjusted EBITDA for the Specialty Hospital segment increased 13.8% to $78.2 million compared to $68.8 million for the same quarter, prior year. The Adjusted EBITDA margin for the segment was 19.5% for the fourth quarter of 2009, compared to 17.9% for the same quarter, prior year. The Adjusted EBITDA margin for the hospitals opened or acquired as of January 1, 2008 and operated by Select throughout both periods was 21.1% for the fourth quarter of 2009, compared to 20.8% for the same quarter, prior year.

For the year ended December 31, 2009, net operating revenues for all of Select’s hospitals increased 4.7% to $1,557.8 million compared to $1,488.4 million for the prior year. Total patient days for the year ended December 31, 2009 were 1,015,500, admissions were 42,674 and net revenue per patient day was $1,507. This compares to 1,005,719 days, 41,177 admissions and net revenue per patient day of $1,453 for the prior year. For the hospitals opened or acquired as of January 1, 2008 and operated by Select throughout both periods, patient days for the year ended December 31, 2009 were 944,275 and admissions were 39,666, compared to 964,114 days and 39,514 admissions in the prior year. Adjusted EBITDA for the Specialty Hospital segment for the year ended December 31, 2009 increased 22.8% to $290.4 million compared to $236.4 million for the prior year. The Adjusted EBITDA margin for the segment for the year ended December 31, 2009 was 18.6%, compared to 15.9% for the prior year. The Adjusted EBITDA margin for the hospitals opened or acquired as of January 1, 2008 and operated by Select throughout both periods was 20.1% for the year ended December 31, 2009, compared to 18.2% for the prior year.

Outpatient Rehabilitation

At December 31, 2009, Select operated 961 outpatient clinics. This compares to 956 outpatient clinics at December 31, 2008. For the fourth quarter of 2009, net operating revenues for the segment increased 5.4% to $172.1 million compared to $163.4 million for the same quarter, prior year. Adjusted EBITDA for the Outpatient Rehabilitation segment for the fourth quarter increased 26.8% to $21.6 million compared to $17.0 million for the same quarter, prior year. The Adjusted EBITDA margin for the segment for the quarter was 12.5% compared to 10.4% in the same quarter, prior year. Patient visits for the quarter were 1,116,316 compared to 1,103,589 for the same quarter, prior year. Net revenue per visit for the quarter ended December 31, 2009 was $102 compared to $101 for the same quarter, prior year.

For the year ended December 31, 2009, net operating revenues for the segment increased 2.6% to $681.9 million compared to $664.8 million for the prior year. Adjusted EBITDA for the Outpatient Rehabilitation segment for the year ended December 31, 2009 increased 15.3% to $89.1 million compared to $77.3 million for the prior year. The Adjusted EBITDA margin for the year ended December 31, 2009 was 13.1% compared to 11.6% in the prior year. Patient visits for the year ended December 31, 2009 were 4,502,049 compared to 4,533,727 for the prior year. Net revenue per visit was $102 for both the year ended December 31, 2009 and the prior year.

Initial Public Offering of Common Stock

On September 30, 2009 Select completed an initial public offering of 30,000,000 shares at a price to the public of $10.00 per share, and on October 28, 2009, the underwriters exercised their over-allotment option to purchase an additional 3,602,700 shares at the same price. The total net proceeds to Select after deducting underwriting discounts and commissions and offering expenses was approximately $312.5 million. Select used the proceeds from the offering to repay $258.4 million of revolving and term loans outstanding under its senior secured credit facility and to make payments to executive officers under the Long Term Cash Incentive Plan of $18.0 million. The remaining proceeds were used for general corporate purposes.

Business Outlook

Select reaffirms its financial guidance for 2010 as disclosed in the presentation attached as an exhibit to Select’s Form 8-K filed with the SEC on January 11, 2010.

Conference Call

Select will host a conference call regarding its fourth quarter and full year results and its business outlook on Friday, February 19, 2010, at 11:00 am EST. The domestic dial in number for the call is 1-800-291-5365. The international dial in number is 1-617-614-3922. The passcode for the call is 45516325. The conference call will be webcast simultaneously and can be accessed at Select Medical Holdings Corporation’s website http://www.selectmedicalcorp.com.

* * * * *

Select Medical Holdings Corporation is a leading operator of specialty hospitals in the United States. As of December 31, 2009, Select operated 89 long term acute care hospitals and six acute medical rehabilitation hospitals in 25 states. Select is also a leading operator of outpatient rehabilitation clinics in the United States, with approximately 961 locations in 37 states and the District of Columbia. Select also provides medical rehabilitation services on a contract basis at nursing homes, hospitals, assisted living and senior care centers, schools and worksites. Information about Select is available at http://www.selectmedicalcorp.com/

Certain statements contained herein that are not descriptions of historical facts are “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements due to factors including the following:

•

additional changes in government reimbursement for our services may result in a reduction in net operating revenues, an increase in costs and a reduction in profitability;

•

the failure of our long term acute care hospitals, or LTCHs, to maintain their status as such may cause our net operating revenues and profitability to decline;

•

the failure of our facilities operated as “hospitals within hospitals,” or HIHs, to qualify as hospitals separate from their host hospitals may cause our net operating revenues and profitability to decline;

•

implementation of modifications to the admissions policies for our inpatient rehabilitation facilities, as required to achieve compliance with Medicare guidelines, may result in a loss of patient volume at these hospitals and, as a result, may reduce our future net operating revenues and profitability;

•

a government investigation or assertion that we have violated applicable regulations may result in sanctions or reputational harm and increased costs;

•

future acquisitions or joint ventures may prove difficult or unsuccessful, use significant resources or expose us to unforeseen liabilities;

•

private third-party payors for our services may undertake future cost containment initiatives that limit our future net operating revenues and profitability;

•

the failure to maintain established relationships with the physicians in our markets could reduce our net operating revenues and profitability;

•

shortages in qualified nurses or therapists could increase our operating costs significantly;

•

competition may limit our ability to grow and result in a decrease in our net operating revenues and profitability;

•

the loss of key members of our management team could significantly disrupt our operations;

•

the effect of claims asserted against us or lack of adequate available insurance could subject us to substantial uninsured liabilities;

•

the ability to obtain any necessary or desired waiver or amendment from our existing lenders may be difficult due to the current uncertainty in the credit markets; and

•

the inability to draw funds under our senior secured credit facility because of lender defaults.

Investor inquiries:

Joel Veit, 717/972-1100

I. Condensed Consolidated Statements of Operations
(In thousands, except per share amounts)
(unaudited)
For the Three Months Ended December 31, 2008 and 2009

										%
		2008				2009				Change
Net operating revenues		$	547,099			$	573,543				4.8	%
Costs and expenses:
Cost of services			448,819				466,664				4.0	%
General and administrative			9,680				12,131				25.3	%
Bad debt expense			12,504				7,194				(42.5	)%
Depreciation and amortization			18,611				17,635				(5.2	)%
Income from operations			57,485				69,919				21.6	%
Gain (loss) on early retirement of debt			912				(2,870	)			N/M
Other expense			—				(632	)			N/M
Interest income			196				10				(94.9	)%
Interest expense			(36,291	)			(30,688	)			(15.4	)%
Income from operations before income taxes			22,302				35,739				60.3	%
Income tax expense			12,201				4,440				(63.6	)%
Net income			10,101				31,299				209.9	%
Less: Net income attributable to non-controlling interests			1,290				1,388				7.6	%
Net income attributable to Select Medical Holdings Corporation			8,811				29,911				239.5	%
Less: Preferred dividends			6,403				—				N/M
Net income available to common stockholders and participating securities		$	2,408			$	29,911				N/M
Income per common share:
Basic		$	0.04			$	0.19				375.0	%
Diluted		$	0.04			$	0.19				375.0	%

N/M = Not Meaningful

II. Condensed Consolidated Statements of Operations
(In thousands, except per share amounts)
(unaudited)
For the Year Ended December 31, 2008 and 2009

										%
		2008				2009				Change
Net operating revenues		$	2,153,362			$	2,239,871				4.0	%
Costs and expenses:
Cost of services			1,791,841				1,819,771				1.6	%
General and administrative			45,523				72,409				59.1	%
Bad debt expense			47,804				40,872				(14.5	)%
Depreciation and amortization			71,786				70,981				(1.1	)%
Income from operations			196,408				235,838				20.1	%
Gain on early retirement of debt			912				13,575				N/M
Other expense			—				(632	)			N/M
Interest income			471				92				(80.5	)%
Interest expense			(145,894	)			(132,469	)			(9.2	)%
Income from operations before income taxes			51,897				116,404				124.3	%
Income tax expense			26,063				37,516				43.9	%
Net income			25,834				78,888				205.4	%
Less: Net income attributable to non-controlling interests			3,393				3,606				6.3	%
Net income attributable to Select Medical Holdings Corporation			22,441				75,282				235.5	%
Less: Preferred dividends			24,972				19,537				(21.8	)%
Net income available to common stockholders and participating securities		$	(2,531	)		$	55,745				N/M
Income per common share:
Basic		$	(0.04	)		$	0.61				N/M
Diluted		$	(0.04	)		$	0.61				N/M

N/M = Not Meaningful

III. Condensed Consolidated Balance Sheets
(In thousands)
(unaudited)

		December 31,				December 31,
		2008				2009
ASSETS
Cash		$	64,260			$	83,680
Accounts receivable, net			312,418				307,079
Current deferred tax asset			61,925				48,535
Prepaid income taxes			7,362				11,179
Other current assets			20,897				24,240
Total Current Assets			466,862				474,713
Property and equipment, net			471,065				466,131
Goodwill			1,506,661				1,548,269
Other identifiable intangibles			74,078				65,297
Assets held for sale			12,542				11,342
Other assets			48,261				36,481
Total Assets		$	2,579,469			$	2,602,233
LIABILITIES AND EQUITY
Payables and accruals		$	339,446			$	299,796
Current portion of long-term debt			9,046				4,145
Total Current Liabilities			348,492				303,941
Long-term debt, net of current portion			1,770,879				1,401,426
Non-current deferred tax liability			42,918				66,768
Other non-current liabilities			67,709				60,543
Preferred stock			515,872				—
Total equity			(166,401	)			769,555
Total Liabilities and Equity		$	2,579,469			$	2,602,233

IV. Condensed Consolidated Statements of Cash Flows
(In thousands)
(unaudited)
For the Year Ended December 31, 2008 and 2009

		2008				2009
Operating activities
Net income		$	25,834			$	78,888
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			71,786				70,981
Provision for bad debts			47,804				40,872
Gain on early retirement of debt			(912	)			(13,575	)
Loss (gain) from disposal of assets			546				(122	)
Non-cash loss from interest rate swaps			—				632
Non-cash stock compensation expense			2,093				5,147
Amortization of debt discount			1,492				1,681
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
Accounts receivable			(88,545	)			(35,455	)
Other current assets			8,230				(1,117	)
Other assets			16,913				6,114
Accounts payable			(1,351	)			963
Due to third-party payors			(9,363	)			(3,804	)
Accrued expenses and deferred income taxes			32,911				14,434
Net cash provided by operating activities			107,438				165,639
Investing activities
Purchases of property and equipment			(56,504	)			(57,877	)
Proceeds from sale of business units			2,666				—
Proceeds from sale of property			743				1,341
Insurance proceeds			281				—
Acquisition of businesses, net of cash acquired			(7,624	)			(21,381	)
Net cash used in investing activities			(60,438	)			(77,917	)
Financing activities
Proceeds from initial public offering, net of fees			—				315,866
Payment of initial public offering costs			(1,326	)			(1,737	)
Borrowings on revolving credit facility			407,000				193,000
Payments on revolving credit facility			(377,000	)			(343,000	)
Payment on credit facility term loan			(6,800	)			(173,433	)
Repurchase of 7 5/8% senior subordinated notes			(1,040	)			(30,114	)
Repurchase of senior floating rate notes			—				(6,468	)
Borrowings of other debt			—				7,189
Principal payments on seller and other debt			(5,630	)			(7,275	)
Repurchase of common and preferred stock			(612	)			(80	)
Proceeds from exercise of stock options			90				146
Proceeds from (repayment of) bank overdrafts			6				(21,130	)
Equity contribution and loans from non-controlling interests			—				1,500
Distributions to non-controlling interests			(1,957	)			(2,766	)
Net cash provided by (used in) financing activities			12,731				(68,302	)
Net increase in cash and cash equivalents			59,731				19,420
Cash and cash equivalents at beginning of period			4,529				64,260
Cash and cash equivalents at end of period		$	64,260			$	83,680
Supplemental Cash Flow Information
Cash paid for interest		$	135,838			$	126,695
Cash paid for taxes		$	5,313			$	18,084

V. Key Statistics
(unaudited)
For the Three Months Ended December 31, 2008 and 2009

										%
		2008				2009				Change
Specialty Hospitals (a)
Number of hospitals — end of period			93				95				2.2	%
Net operating revenues (,000)		$	383,681			$	401,399				4.6	%
Number of patient days			249,626				258,013				3.4	%
Number of admissions			10,286				10,899				6.0	%
Net revenue per patient day (b)		$	1,509			$	1,528				1.3	%
Adjusted EBITDA (,000)		$	68,771			$	78,248				13.8	%
Adjusted EBITDA margin — all hospitals			17.9	%			19.5	%			8.9	%
Adjusted EBITDA margin — same store hospitals (c)			20.8	%			21.1	%			1.4	%
Outpatient Rehabilitation
Number of clinics — end of period			956				961				0.5	%
Net operating revenues (,000)		$	163,385			$	172,132				5.4	%
Number of visits			1,103,589				1,116,316				1.2	%
Revenue per visit (d)		$	101			$	102				1.0	%
Adjusted EBITDA (,000)		$	17,031			$	21,596				26.8	%
Adjusted EBITDA margin			10.4	%			12.5	%			20.2	%

VI. Key Statistics
(unaudited)
For the Year Ended December 31, 2008 and 2009

										%
		2008				2009				Change
Specialty Hospitals (a)
Number of hospitals — end of period			93				95				2.2	%
Net operating revenues (,000)		$	1,488,412			$	1,557,821				4.7	%
Number of patient days			1,005,719				1,015,500				1.0	%
Number of admissions			41,177				42,674				3.6	%
Net revenue per patient day (b)		$	1,453			$	1,507				3.7	%
Adjusted EBITDA (,000)		$	236,388			$	290,370				22.8	%
Adjusted EBITDA margin — all hospitals			15.9	%			18.6	%			17.0	%
Adjusted EBITDA margin — same store hospitals (c)			18.2	%			20.1	%			10.4	%
Outpatient Rehabilitation
Number of clinics — end of period			956				961				0.5	%
Net operating revenues (,000)		$	664,760			$	681,892				2.6	%
Number of visits			4,533,727				4,502,049				(0.7	)%
Revenue per visit (d)		$	102			$	102				0.0	%
Adjusted EBITDA (,000)		$	77,279			$	89,072				15.3	%
Adjusted EBITDA margin			11.6	%			13.1	%			12.9	%

VII. Net Income to Adjusted EBITDA Reconciliation
(In thousands)
(unaudited)
For the Three Months and Year Ended December 31, 2008 and 2009

The following table reconciles net income to Adjusted EBITDA for Select. Adjusted EBITDA is used by Select to report its segment performance. Adjusted EBITDA is defined as net income before interest, income taxes, depreciation and amortization, stock compensation expense, other expense, long-term incentive compensation, gain (loss) on early retirement of debt and non-controlling interest. We believe that the presentation of Adjusted EBITDA is important to investors because Adjusted EBITDA is used by management to evaluate financial performance and determine resource allocation for each of our operating units.

Adjusted EBITDA is not a measure of financial performance under generally accepted accounting principles. Items excluded from Adjusted EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA should not be considered in isolation or as an alternative to, or substitute for, net income, cash flows generated by operations, investing or financing activities, or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because Adjusted EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, Adjusted EBITDA as presented may not be comparable to other similarly titled measures of other companies.

		Three Months Ended December 31,								Year Ended December 31,
		2008				2009				2008				2009
Net income		$	8,811			$	29,911			$	22,441			$	75,282
Non-controlling interest			1,290				1,388				3,393				3,606
Income tax expense			12,201				4,440				26,063				37,516
Other expense			—				632				—				632
Interest expense, net			36,095				30,678				145,423				132,377
Loss (gain) on early retirement of debt			(912	)			2,870				(912	)			(13,575	)
Long-term incentive compensation			—				—				—				18,261
Stock compensation expense
Included in general and administrative			337				181				1,953				4,775
Included in cost of services			59				171				140				372
Depreciation and amortization			18,611				17,635				71,786				70,981
Adjusted EBITDA		$	76,492			$	87,906			$	270,287			$	330,227
Specialty hospitals		$	68,771			$	78,248			$	236,388			$	290,370
Outpatient rehabilitation			17,031				21,596				77,279				89,072
Other (1)			(9,310	)			(11,938	)			(43,380	)			(49,215	)
Adjusted EBITDA		$	76,492			$	87,906			$	270,287			$	330,227

The following tables reconcile specialty hospital same store information.

		Three Months Ended
		December 31, 2008				December 31, 2009
Specialty hospitals net operating revenue		$	383,681			$	401,399
Less: Specialty hospitals in development, opened or closed after 1/1/08			19,907				28,921
Specialty hospitals same store net operating revenue		$	363,774			$	372,478
Specialty hospitals Adjusted EBITDA		$	68,771			$	78,248
Less: Specialty hospitals in development, opened or closed after 1/1/08			(6,716	)			(460	)
Specialty hospitals same store Adjusted EBITDA		$	75,487			$	78,708
All specialty hospitals Adjusted EBITDA margin			17.9	%			19.5	%
Specialty hospitals same store Adjusted EBITDA margin			20.8	%			21.1	%

		Year Ended
		December 31, 2008				December 31, 2009
Specialty hospitals net operating revenue		$	1,488,412			$	1,557,821
Less: Specialty hospitals in development, opened or closed after 1/1/08			56,363				108,806
Specialty hospitals same store net operating revenue		$	1,432,049			$	1,449,015
Specialty hospitals Adjusted EBITDA		$	236,388			$	290,370
Less: Specialty hospitals in development, opened or closed after 1/1/08			(24,303	)			(1,452	)
Specialty hospitals same store Adjusted EBITDA		$	260,691			$	291,822
All specialty hospitals Adjusted EBITDA margin			15.9	%			18.6	%
Specialty hospitals same store Adjusted EBITDA margin			18.2	%			20.1	%

VIII. Reconciliation of Net Income Per Share to Adjusted Net Income Per Share
(In thousands, except per share amounts)
(unaudited)
For the Three Months Ended December 31, 2008 and 2009

		2008				Per Share (a)				2009				Per Share (a)
Net income		$	10,101			$	0.17			$	31,299			$	0.20
Net income attributable to non-controlling interests			1,290				0.02				1,388				0.01
Net income attributable to Select Medical Holdings Corporation			8,811				0.15				29,911				0.19
Less: Preferred dividends			6,403				0.11				—				0.00
Net income available to common stockholders and participating securities			2,408				0.04				29,911				0.19
Long-term incentive compensation related to initial public offering			—				0.00				—				0.00
Stock compensation related to initial public offering			—				0.00				—				0.00
Loss (gain) on early retirement of debt			(912	)			(0.01	)			2,870				0.02
Estimated income tax expense (benefit) (b)			490				0.00				(955	)			(0.01	)
			1,986				0.03				31,826				0.20
Allocation to participating securities:
Less: Earnings allocated to preferred stockholders			194				0.00				—				0.00
Less: Earnings allocated to unvested restricted stockholders			39				0.00				62				0.00
Adjusted net income available to common stockholders		$	1,753			$	0.03			$	31,764			$	0.20
Adjustment for dilution							0.00								0.00
Adjusted net income available to common stockholders — diluted shares						$	0.03							$	0.20
Weighted average common shares outstanding:
Basic							60,125								158,457
Diluted							60,609								158,889

IX. Reconciliation of Net Income Per Share to Adjusted Net Income Per Share
(In thousands, except per share amounts)
(unaudited)
For the Year Ended December 31, 2008 and 2009

		2008				Per Share (a)				2009				Per Share (a)
Net income		$	25,834			$	0.44			$	78,888			$	0.92
Net income attributable to non-controlling interests			3,393				0.07				3,606				0.04
Net income attributable to Select Medical Holdings Corporation			22,441				0.37				75,282				0.88
Less: Preferred dividends			24,972				0.41				19,537				0.23
Net income (loss) available to common stockholders and participating securities			(2,531	)			(0.04	)			55,745				0.65
Long-term incentive compensation related to initial public offering			—				0.00				18,261				0.21
Stock compensation related to initial public offering			—				0.00				3,689				0.04
Gain on early retirement of debt			(912	)			(0.02	)			(13,575	)			(0.16	)
Estimated income tax expense (benefit) (b)			490				0.01				(2,786	)			(0.03	)
			(2,953	)			(0.05	)			61,334				0.71
Allocation to participating securities:
Less: Earnings (loss) allocated to preferred stockholders			(296	)			(0.01	)			3,328				0.03
Less: Earnings allocated to unvested restricted stockholders			—				0.00				472				0.01
Adjusted net income (loss) available to common stockholders		$	(2,657	)		$	(0.04	)		$	57,534			$	0.67
Adjustment for dilution							0.00								0.00
Adjusted net income (loss) available to common stockholders — diluted shares						$	(0.04	)						$	0.67
Weighted average common shares outstanding:
Basic							59,566								85,587
Diluted							59,566								86,045